P

Inventor

MOYO VICTOR

US16 patents
⚠️ This page may combine multiple inventors who share the name “MOYO VICTOR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

IPSEN BIOPHARM LTD

7 patents
US9717724B2Aug 1, 2017

Methods for treating pancreatic cancer using combination therapies

IPSEN BIOPHARM LTD14 citations91
US10980795B2Apr 20, 2021

Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan

IPSEN BIOPHARM LTD8 citations83
US10478428B2Nov 19, 2019

Combination therapy for cancer treatment

IPSEN BIOPHARM LTD11 citations82
US9895365B2Feb 20, 2018

Combination therapy for cancer treatment

IPSEN BIOPHARM LTD10 citations82
US11369597B2Jun 28, 2022

Methods for treating pancreatic cancer using combination therapies

IPSEN BIOPHARM LTD4 citations72
US11844795B2Dec 19, 2023

Combination therapy for cancer treatment

IPSEN BIOPHARM LTD2 citations71
US12364691B2Jul 22, 2025

Methods for treating pancreatic cancer using combination therapies

IPSEN BIOPHARM LTD0 citations61

MERRIMACK PHARMACEUTICALS INC

6 patents
US9492442B2Nov 15, 2016

Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan

MERRIMACK PHARMACEUTICALS INC19 citations91
US9452162B2Sep 27, 2016

Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan

MERRIMACK PHARMACEUTICALS INC12 citations91
US9364473B2Jun 14, 2016

Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan

MERRIMACK PHARMACEUTICALS INC12 citations91
US9339497B2May 17, 2016

Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan

MERRIMACK PHARMACEUTICALS INC17 citations91
US9518130B2Dec 13, 2016

Use of ERBB3 inhibitors in the treatment of triple negative and basal-like breast cancers

MERRIMACK PHARMACEUTICALS INC4 citations70
US9913901B2Mar 13, 2018

Combination therapy for treating HER2-positive cancers

MERRIMACK PHARMACEUTICALS INC0 citations45

L E A F HOLDINGS GROUP LLC

2 patents
US12115256B2Oct 15, 2024

Targeted liposomal gemcitabine and methods thereof

L E A F HOLDINGS GROUP LLC0 citations59
US10940112B2Mar 9, 2021

Targeted liposomal gemcitabine compositions and methods thereof

L E A F HOLDINGS GROUP LLC0 citations59

MOYO VICTOR

1 patent
US8895001B2Nov 25, 2014

Use of ErbB3 inhibitors in the treatment of triple negative and basal-like breast cancers

MOYO VICTOR14 citations77